Overview

Ketamine/Placebo Family History Positive Study

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
VA Connecticut Healthcare System
Treatments:
Ketamine